52 results
-
List item
Human medicine European public assessment report (EPAR): Aerius
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 49, Authorised, Last updated: 15/12/2022Aerius Rhinitis, Allergic Respiratory … assessment report (EPAR) for Aerius. It explains how the The committee … the conditions of use for Aerius. What is Aerius? Aerius is a medicine containing … -
List item
Human medicine European public assessment report (EPAR): Desloratadine ratiopharm
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 13/01/2012,
, Revision: 12, Authorised, Last updated: 24/06/2022
authorised in the EU called Aerius. For more information on generic … with the reference medicine, Aerius, and do not need to be repeated … and to be bioequivalent to Aerius. Therefore, the Agency’s … -
List item
Human medicine European public assessment report (EPAR): Dasselta
desloratadine, Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria
Date of authorisation: 28/11/2011,, Revision: 13, Authorised, Last updated: 09/06/2022
European Union (EU) called Aerius. What is Dasselta used for … to the reference medicine, Aerius. Two medicines are bioequivalent … and to be bioequivalent to Aerius. Therefore, the CHMP’s view … -
List item
Human medicine European public assessment report (EPAR): Desloratadine Actavis
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 13/01/2012,, Revision: 15, Authorised, Last updated: 09/06/2022
European Union (EU) called Aerius. What is Desloratadine Actavis … to the reference medicine, Aerius. Two medicines are bioequivalent … and to be bioequivalent to Aerius. Therefore, the Committee … -
List item
Human medicine European public assessment report (EPAR): Desloratadine Teva
desloratadine, Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
Date of authorisation: 24/11/2011,, Revision: 18, Authorised, Last updated: 09/06/2022
European Union (EU) called Aerius. What is Desloratadine Teva … to the reference medicine, Aerius. Two medicines are bioequivalent … and to be bioequivalent to Aerius. Therefore, the Committee … -
List item
Human medicine European public assessment report (EPAR): Allex
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Withdrawn, Last updated: 31/12/2009use Therapeutic indication Aerius is indicated for the relief … containing desloratadine i.e. Aerius, Azomyr and Neoclarityn … -
List item
Press release: Krka, d.d., Novo mesto withdraws its marketing authorisation application for Desloratadine Krka (desloratadine)
Last updated: 19/10/2011Desloratadine Krka is a generic of Aerius which has been authorised … Desloratadine Krka is a generic of Aerius which has been authoris 15 … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,18-21 February 2008
CHMP, Last updated: 21/02/2008Aerius and Neoclarityn (desloratadine … urticaria to urticaria. Azomyr, Aerius and Neoclarityn are currently … -
List item
Human medicine European public assessment report (EPAR): Neoclarityn
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 45, Authorised, Last updated: 15/12/2022 -
List item
Human medicine European public assessment report (EPAR): Azomyr
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 51, Authorised, Last updated: 15/12/2022 -
List item
Human medicine European public assessment report (EPAR): Opulis
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Withdrawn, Last updated: 19/05/2004containing desloratadine i.e. Aerius, Azomyr and Neoclarityn … -
List item
Withdrawn application: Desloratadine Krka
desloratadine, date of withdrawal: 14/10/2011, Initial authorisation, Last updated: 17/11/2011system. Desloratadine Krka is a generic of Aerius which has been authorised … with the reference product Aerius. A question and answer document … -
List item
Orphan designation: hydrocortisone for: Treatment of adrenal insufficiency
Date of designation: 22/05/2006, Expired, Last updated: 25/11/2021 -
List item
Orphan designation: hydrocortisone for: Treatment of congenital adrenal hyperplasia
Date of designation: 27/07/2005, Positive, Last updated: 14/06/2021 -
List item
Orphan designation: dexamethasone for: Treatment of multiple myeloma
Date of designation: 09/06/2010, Withdrawn, Last updated: 12/02/2018kezelése Italian Desametasone (compressa da 40 mg) Trattamento del … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2022
Written procedure, from 16/08/2022 to 19/08/2022, Last updated: 04/10/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
CHMP: Agendas, minutes and highlights
Last updated: 08/02/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2021 to 22/04/2021, Last updated: 07/12/2021 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 17/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 21/06/2021 to 24/06/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-29 January 2021
Virtual meeting, from 25/01/2021 to 29/01/2021, Last updated: 04/03/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 12/08/2022 -
List item
Sampling and testing
Last updated: 28/03/2019